<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34715312</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5921</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of clinical epidemiology</Title><ISOAbbreviation>J Clin Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Estimating total morbidity burden of COVID-19: relative importance of death and disability.</ArticleTitle><Pagination><StartPage>54</StartPage><EndPage>59</EndPage><MedlinePgn>54-59</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinepi.2021.10.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0895-4356(21)00339-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Calculations of disease burden of COVID-19, used to allocate scarce resources, have historically considered only mortality. However, survivors often develop postinfectious 'long-COVID' similar to chronic fatigue syndrome; physical sequelae such as heart damage, or both. This paper quantifies relative contributions of acute case fatality, delayed case fatality, and disability to total morbidity per COVID-19 case.</AbstractText><AbstractText Label="STUDY DESIGN AND SETTING">Healthy life years lost per COVID-19 case were computed as the sum of (incidence*disability weight*duration) for death and long-COVID by sex and 10-year age category in three plausible scenarios.</AbstractText><AbstractText Label="RESULTS">In all models, acute mortality was only a small share of total morbidity. For lifelong moderate symptoms, healthy years lost per COVID-19 case ranged from 0.92 (male in his 30s) to 5.71 (girl under 10) and were 3.5 and 3.6 for the oldest females and males. At higher symptom severities, young people and females bore larger shares of morbidity; if survivors' later mortality increased, morbidity increased most in young people of both sexes.</AbstractText><AbstractText Label="CONCLUSIONS">Under most conditions most COVID-19 morbidity was in survivors. Future research should investigate incidence, risk factors, and clinical course of long-COVID to elucidate total disease burden, and decisionmakers should allocate scarce resources to minimize total morbidity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Author. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Maia P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Public Health and Preventive Medicine, St. George's University School of Medicine, True Blue, Grenada, West Indies. Electronic address: Maia.phillips.smith@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Epidemiol</MedlineTA><NlmUniqueID>8801383</NlmUniqueID><ISSNLinking>0895-4356</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087509" MajorTopicYN="N">Disability-Adjusted Life Years</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="N">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">DALY</Keyword><Keyword MajorTopicYN="N">Disability</Keyword><Keyword MajorTopicYN="N">Disability-adjusted life year</Keyword><Keyword MajorTopicYN="N">Equity</Keyword><Keyword MajorTopicYN="N">Gender</Keyword><Keyword MajorTopicYN="N">QALY</Keyword><Keyword MajorTopicYN="N">SARS-COV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34715312</ArticleId><ArticleId IdType="pmc">PMC8547965</ArticleId><ArticleId IdType="doi">10.1016/j.jclinepi.2021.10.018</ArticleId><ArticleId IdType="pii">S0895-4356(21)00339-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Undurraga E.A., Chowell G., Mizumoto K. COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March&#x2013;August 2020. Infect Dis Poverty. 2021;10(11):2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7854021</ArticleId><ArticleId IdType="pubmed">33531085</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 &#x201c;Long Haulers&#x201d; stump experts. JAMA. 2020;324(14):1381&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal AS, Bradley AS, Bishop KN, Kiani-Alikhan S, Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun. 2012;26(1):24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">21756995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert NJ. COVID-19 &#x201c;Long Hauler&#x201d; Symptoms Survey Report; 2020. Survivor corps.</Citation></Reference><Reference><Citation>Dimmock ME Mirin AA, Jason LA. Estimating the disease burden of ME/CFS in the United States and its relation to research funding. J Med Therap. 2016;1(1):1&#x2013;7. doi: 10.15761/JMT.1000102.</Citation><ArticleIdList><ArticleId IdType="doi">10.15761/JMT.1000102</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557. Published online July 27, 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the COMEBAC Study Group Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021;325(15):1525&#x2013;1534. doi: 10.1001/jama.2021.3331. Published online March 17, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Social security period life table, 2017. In: Administration SS, editor.; 2017 https://www.ssa.gov/oact/HistEst/PerLifeTables/2017/PerLifeTables2017.</Citation></Reference><Reference><Citation>CDC US. Myalgic encephalomyelitis/chronic fatigue syndrome: what is ME/CFS? In: Services HaH, editor.; 2018.</Citation></Reference><Reference><Citation>Sawalha K, Abozenah M, Kadado AJ, Battisha A, Al-Akchar M, Salerno C, et al. Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovasc Revasc Med. 2021;2021(23):107&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434380</ArticleId><ArticleId IdType="pubmed">32847728</ArticleId></ArticleIdList></Reference><Reference><Citation>Judd A. UK Office for National Statistics; 2021. COVID-19 schools infection survey, England: prevalence of ongoing symptoms following coronavirus (COVID-19) infection in school pupils and staff: July 2021.</Citation></Reference><Reference><Citation>Ayoubkhani D;, Pawelek P;, Bosworth M. UK Office for National Statistics; 2021. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: Estimates of the prevalence of self-reported "long COVID" and associated activity limitation, using UK Coronavirus (COVID-19) Infection Survey data.</Citation></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. For the gemelli against COVID-19 post-acute care study group. persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur Respir J. 2021 (epub ahead of print)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Israeli Ministry of Health; 2021. Results of the long-COVID survey among children in Israel.</Citation></Reference><Reference><Citation>Ledford H. Why do COVID death rates seem to be falling? Nature. 2020;587(2020):190&#x2013;192. doi: 10.1038/d41586-020-03132-4. 11 November 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-03132-4</ArticleId><ArticleId IdType="pubmed">33177662</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MP. Role of ascertainment bias in determining case fatality rate of COVID-19. J Epidemiol Global Health. 2021;11(2):143&#x2013;145. doi: 10.2991/jegh.k.210401.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.2991/jegh.k.210401.001</ArticleId><ArticleId IdType="pmc">PMC8242115</ArticleId><ArticleId IdType="pubmed">33876593</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamowicz JL, Caikauskaite I, Friedberg F. Defining recovery in chronic fatigue syndrome: a critical review. Qual Life Res. 2014;23:2407&#x2013;2416.</Citation><ArticleIdList><ArticleId IdType="pubmed">24791749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>